HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $15 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $15 price target.
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target.
B of A Securities Upgrades Portland Gen Electric to Buy, Announces $52 Price Target
B of A Securities analyst Julien Dumoulin-Smith upgrades Portland Gen Electric (NYSE:POR) from Neutral to Buy and announces $52 price target.
Jefferies Initiates Coverage On Academy Sports with Buy Rating, Announces Price Target of $73
Jefferies analyst Anna Glaessgen initiates coverage on Academy Sports (NASDAQ:ASO) with a Buy rating and announces Price Target of $73.
JP Morgan Upgrades Vermilion Energy to Overweight
JP Morgan analyst Arun Jayaram upgrades Vermilion Energy (NYSE:VET) from Neutral to Overweight.
JP Morgan Downgrades Ovintiv to Neutral, Lowers Price Target to $53
JP Morgan analyst Arun Jayaram downgrades Ovintiv (NYSE:OVV) from Overweight to Neutral and lowers the price target from $59 to $53.
HC Wainwright & Co. Reiterates Buy on TRX Gold, Maintains $1.1 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates TRX Gold (AMEX:TRX) with a Buy and maintains $1.1 price target.
Needham Reiterates Buy on Airbnb, Maintains $155 Price Target
Needham analyst Bernie McTernan reiterates Airbnb (NASDAQ:ABNB) with a Buy and maintains $155 price target.
JonesTrading Initiates Coverage On Trevi Therapeutics with Buy Rating, Announces Price Target of $7
JonesTrading analyst Sean Kim initiates coverage on Trevi Therapeutics (NASDAQ:TRVI) with a Buy rating and announces Price Target of $7.
JonesTrading Initiates Coverage On Durect with Buy Rating, Announces Price Target of $37
JonesTrading analyst Sean Kim initiates coverage on Durect (NASDAQ:DRRX) with a Buy rating and announces Price Target of $37.